Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Acute Kidney Injury D058186 34 associated lipids
Airway Remodeling D056151 3 associated lipids
Acute Coronary Syndrome D054058 11 associated lipids
Hypoalphalipoproteinemias D052456 5 associated lipids
Atherosclerosis D050197 85 associated lipids
Dyslipidemias D050171 7 associated lipids
Cholecystitis, Acute D041881 1 associated lipids
Pulmonary Disease, Chronic Obstructive D029424 16 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Coronary Stenosis D023921 6 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Tanaka S et al. High dose of inhaled fluticasone reduces high levels of urinary leukotriene E4 in the early morning in mild and moderate nocturnal asthma. 2003 Chest pmid:14605047
Pestel S et al. Inhibition of prostaglandin D2 clearance in rat hepatocytes by the thromboxane receptor antagonists daltroban and ifetroban and the thromboxane synthase inhibitor furegrelate. 2003 Biochem. Pharmacol. pmid:12906929
Cabrera DM et al. A thromboxane A(2) system in the Atlantic stingray, Dasyatis sabina. 2003 Gen. Comp. Endocrinol. pmid:12568793
Nemr R et al. Effects of nicotine on thromboxane/prostacyclin balance in myocardial ischemia. 2003 Prostaglandins Leukot. Essent. Fatty Acids pmid:12591002
Eatman D et al. Influences of prostanoids and nitric oxide on post-suspension hypotension in female Sprague-Dawley rats. 2003 Prostaglandins Leukot. Essent. Fatty Acids pmid:12591003
Patel YM et al. Evidence for a role for Galphai1 in mediating weak agonist-induced platelet aggregation in human platelets: reduced Galphai1 expression and defective Gi signaling in the platelets of a patient with a chronic bleeding disorder. 2003 Blood pmid:12609843
Hausman N et al. Antenatal administration of celecoxib, a selective cyclooxygenase (COX)-2 inhibitor, appears to improve placental perfusion in the pregnant rabbit. 2003 Prostaglandins Other Lipid Mediat. pmid:12611495
Basta M et al. F(ab)'2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins. 2003 Nat. Med. pmid:12612546
Fiorucci S et al. Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: a proof of concept endoscopic study. 2003 Gastroenterology pmid:12612897
Vigorita MG et al. Chiral 3,3'-(1,2-ethanediyl)-bis[2-(3,4-dimethoxyphenyl)-4-thiazolidinones] with anti-inflammatory activity. Part 11: evaluation of COX-2 selectivity and modelling. 2003 Bioorg. Med. Chem. pmid:12614885
Ersöz G et al. Effect of sodium selenite treatment on platelet aggregation of streptozotocin-induced diabetic rats. 2003 Thromb. Res. pmid:14698654
Wu X et al. Zileuton, a 5-lipoxygenase inhibitor, increases production of thromboxane A2 and platelet aggregation in patients with asthma. 2003 Am. J. Hematol. pmid:12949886
Reid G et al. The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs. 2003 Proc. Natl. Acad. Sci. U.S.A. pmid:12835412
Bosetti F et al. Valproic acid down-regulates the conversion of arachidonic acid to eicosanoids via cyclooxygenase-1 and -2 in rat brain. 2003 J. Neurochem. pmid:12694395
Gama de Abreu M et al. One-lung ventilation with high tidal volumes and zero positive end-expiratory pressure is injurious in the isolated rabbit lung model. 2003 Anesth. Analg. pmid:12505956
Szebeni J et al. Complement activation during hemorrhagic shock and resuscitation in swine. 2003 Shock pmid:14501949
Tanaka Y et al. Effects of exercise on platelet and aortic functions in aged rats. 2003 Acta Physiol. Scand. pmid:14510779
Vani G et al. Histone H1 modulates immune status in experimental breast cancer. 2003 Chemotherapy pmid:14504437
Villalobos MA et al. Effects of camonagrel, a selective inhibitor of platelet thromboxane synthase, on the platelet-subendothelium interaction. 2003 Pharmacology pmid:12886030
Miceli M et al. Effect of low doses of ethanol on platelet function in long-life abstainers and moderate-wine drinkers. 2003 Life Sci. pmid:12865095
Heller AR et al. Clusterin protects the lung from leukocyte-induced injury. 2003 Shock pmid:12865662
Ziser A et al. Propofol does not induce pulmonary dysfunction in stressed endotoxic pigs receiving Intralipid. 2003 Crit. Care Med. pmid:12847400
Sánchez-Muniz FJ et al. Platelet aggregation, thromboxane production and thrombogenic ratio in postmenopausal women consuming high oleic acid-sunflower oil or palmolein. 2003 Eur J Nutr pmid:14673602
Chen Z et al. [Correlation between TXB2, 6-Keto-PGF1alpha and liver metastasis in rats model with blood stasis]. 2003 Zhong Xi Yi Jie He Xue Bao pmid:15339561
He LQ et al. [Effect and mechanism of Tangshenning Recipe on micro-albuminuria in rats with early diabetic nephropathy]. 2003 Zhong Xi Yi Jie He Xue Bao pmid:15339583
Al-Waili NS and Boni NS Natural honey lowers plasma prostaglandin concentrations in normal individuals. 2003 J Med Food pmid:12935324
Jones AE et al. Inhibition of prostaglandin synthesis during polystyrene microsphere-induced pulmonary embolism in the rat. 2003 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:12639842
De Cristofaro R et al. Lipid and protein oxidation contribute to a prothrombotic state in patients with type 2 diabetes mellitus. 2003 J. Thromb. Haemost. pmid:12871497
Davì G et al. Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. 2003 Circulation pmid:12810609
Al-Madaney MM et al. Effects of lipid-esterified conjugated linoleic acid isomers on platelet function: evidence for stimulation of platelet phospholipase activity. 2003 Biochim. Biophys. Acta pmid:14729070
Fujii S et al. L-arginine reverses p47phox and gp91phox expression induced by high salt in Dahl rats. 2003 Hypertension pmid:14504257
De La Cruz JP et al. Differences in the effects of extended-release aspirin and plain-formulated aspirin on prostanoids and nitric oxide in healthy volunteers. 2003 Fundam Clin Pharmacol pmid:12803576
Guyton K et al. Peroxisome proliferator-activated receptor-gamma agonists modulate macrophage activation by gram-negative and gram-positive bacterial stimuli. 2003 Shock pmid:12813370
Montuschi P et al. Exhaled leukotrienes and prostaglandins in COPD. 2003 Thorax pmid:12832671
Wolfram RM et al. Narghile (water pipe) smoking influences platelet function and (iso-)eicosanoids. 2003 Life Sci. pmid:14575812
Stephenson AH et al. Differential effects of 5,6-EET on segmental pulmonary vasoactivity in the rabbit. 2003 Am. J. Physiol. Heart Circ. Physiol. pmid:12609822
Beck-Speier I et al. Sulfur-related air pollutants induce the generation of platelet-activating factor, 5-lipoxygenase- and cyclooxygenase-products in canine alveolar macrophages via activation of phospholipases A2. 2003 Prostaglandins Other Lipid Mediat. pmid:14518563
Seebacher F and Franklin CE Prostaglandins are important in thermoregulation of a reptile (Pogona vitticeps). 2003 Proc. Biol. Sci. pmid:12952634
Cipollone F et al. Modulation of aspirin-insensitive eicosanoid biosynthesis by 6-methylprednisolone in unstable angina. 2003 Circulation pmid:12515743
Fike CD et al. Arachidonic acid metabolites and an early stage of pulmonary hypertension in chronically hypoxic newborn pigs. 2003 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:12388340
Tsipas G and Morphake P Beneficial effects of a diet rich in a mixture of n - 6/n - 3 essential fatty acids and of their metabolites on cyclosporine - nephrotoxicity. 2003 J. Nutr. Biochem. pmid:14629893
Tsuruta LR et al. Characterization of 11-dehydro-thromboxane B2 recombinant antibody obtained by phage display technology. 2003 Prostaglandins Leukot. Essent. Fatty Acids pmid:12628223
Meune C et al. Aspirin alters arterial function in patients with chronic heart failure treated with ACE inhibitors: a dose-mediated deleterious effect. 2003 Eur. J. Heart Fail. pmid:12798824
Sartin JL et al. Estradiol plus progesterone treatment modulates select elements of the proinflammatory cytokine cascade in steers: attenuated nitric oxide and thromboxane B2 production in endotoxemia. 2003 J. Anim. Sci. pmid:12817503
Ojanen R et al. Single dose of acetylsalicylic acid prevents thromboxane release after tourniquet ischemia. 2003 J Trauma pmid:12777914
Dionne RA et al. Dexamethasone suppresses peripheral prostanoid levels without analgesia in a clinical model of acute inflammation. 2003 J. Oral Maxillofac. Surg. pmid:12966473
Tsipas G and Morphake P Beneficial effects of a diet rich in a mixture of n - 6/n - 3 essential fatty acids and of their metabolites on cyclosporine - nephrotoxicity. 2003 J. Nutr. Biochem. pmid:12948879
Cerletti C et al. Pharmacokinetic and pharmacodynamic differences between two low dosages of aspirin may affect therapeutic outcomes. 2003 Clin Pharmacokinet pmid:12959636
Dai H et al. Effects of diltiazem on platelet activation and cytosolic calcium during percutaneous transluminal coronary angioplasty. 2003 Postgrad Med J pmid:13679549
Liu H et al. Clinical implication of the changes of cAMP, TXA2 and PGI2 in CSF of asphyxiated newborns. 2003 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:12973949